67th American Academy of Neurology Annual Meeting
The 2015 annual meeting of the AAN, the world's largest professional association of neurologists, will feature cutting-edge science and research, practical clinical updates and insight, and more.
Q&A With Natalia Rost of Massachusetts General Hospital: American Academy of Neurology Meeting Provides hope on Several Fronts
Q&A With Matthew Wong, MD, From Wake Forest School of Medicine: Cannabidiol Shows Benefits for Some Young Epilepsy Patients
Q&A With Sibyl E. Wray, MD, From Hope Neurology Multiple Sclerosis Center: Survey Shows Patients Want More Involvement in MS Treatment
Q&A With Raj Kapoor, BMBCh, From University College London Hospital: New Treatment Options for Optic Neuritis Shows 'Exciting' Potential
Q&A With David Newman Toker, MD, From Johns Hopkins University Medical School: Current and Future Treatments for Dizziness and Vestibular Disorders in the Emergency Room
Q&A With David Newman Toker, MD, From Johns Hopkins University Medical School: Diagnosing Dizziness and Vestibular Disorders in the Emergency Room
Q&A With Mark Freedman, MD, of Ottawa Hospital: Developing Medication for Multiple Sclerosis a Long and Complicated Process
Q&A With Mark Freedman, MD, of Ottawa Hospital: Study Results show Benefits of Teriflunomide in Multiple Sclerosis Treatment
Q&A With Jacqueline French, MD, from NYU Comprehensive Epilepsy Center: Debunking Misconceptions on Epilepsy
Q&A With Jacqueline French, MD, from NYU Comprehensive Epilepsy Center: Treating Epilepsy and Looking at Best Practices for Seizure
Q&A With Allan Krumholz, MD, from the University of Maryland: New Seizure Guidelines Suggest Wait and See Approach for Some
Q&A With Allan Krumholz, MD, from the University of Maryland: AAN Announces New Guidelines for Seizure Care
Patients who suffer their first seizure are expected to have several questions. In some instances, one question may be why their doctor is waiting until a second seizure to begin treatment. A new guideline from the American Academy of Neurology looked to answer that question for doctors and patients alike.
Q&A With Oksana Suchowersky MD, FAAN, University of Alberta Hospital: Taking Treatment From the Clinic to Telemedicine
Q&A With Gary Franklin, MD, MPH, FAAN, of the University of Washington: The Opioid Epidemic: Where Do We Go From Here?
Q&A With Oksana Suchowersky MD, FAAN, University of Alberta Hospital: Diagnosing and Treating Hyperkinetic Movement Disorders
Q&A With Carl Bazil, MD, PhD, FAAN of Columbia University: Finding Alternative Treatments for Epilepsy
Q&A With Carl Bazil, MD, PhD, FAAN of Columbia University: When is Surgery the Best Treatment for Epilepsy?
Q&A With Carl Bazil, MD, PhD, FAAN of Columbia University: Diagnosing Epilepsy and Finding the Right Medication
Diagnosing patients with epilepsy can often be an involved process as doctors will likely not see the seizures their patients report suffering. Once a diagnosis is made finding the right treatment can also be a challenge as different patient groups will require different types and doses of a variety of medications.
For patients with Alzheimer's Disease, as their condition worsens it often falls on other members of their family to make decisions about their course of treatment. What they are expected to do and how they make certain decisions can have long lasting impacts on the care of the people with the disease.
Q&A With Gilmore O'Neill of Biogen International: Continuing to Learn About Multiple Sclerosis Treatment
Q&A With Gilmore O'Neill of Biogen International: Weighing the Options for Multiple Sclerosis Medications
Patients with multiple sclerosis (MS) often have sensitivity to heat that worsens their symptoms. In earlier studies with MS patients, a device system that cools body temperature by chilling one palm proved useful in helping them walk faster and longer. But patients need to be motivated to use it successfully.
Fred Grossman, DO, FAPA, who serves as the head of Global Clinical Development and Medical Affairs at Sunovion Pharmaceuticals, discusses recent study results that indicated Aptiom (eslicarbazepine acetate), already approved as adjunct therapy for partial-onset seizures, may be effective as a monotherapy for patients with epilepsy.
As healthy adults age their motor response inhibition may become impaired, according to Ali Shoraka, MD, a Researcher Coordinator at the University of Florida in Gainesville, FL. The study is due to be presented in a poster session on Apr. 20 at the American Academy of Neurology meeting in Washington, DC.
While abnormal eating behaviors are recognized in behavioral frontotemportal dementia (bvFTD) patients, not much has been reported has been found on the effects on their metabolic health until recently, according to lead author Rebekah Ahmed, MD. The study is due to be presented in a poster session on Apr. 20 at the American Academy of Neurology meeting in Washington, DC.
Age and the level of the brain's executive capacity (EC) are connected to the attention that adults give to novel auditory stimuli, according to Kirk Daffner, MD, chief of the division of Cognitive and Behavioral Neurology and director of the Center for Brain/Mind Medicine at Brigham and Women's Hospital in Boston, MA. The findings are set to be presented in a poster session on Apr. 20 at the American Academy of Neurology meeting in Washington, DC.
The American Academy of Neurology's 67th annual meeting starts April 18 in Washington, D.C. and neurologists attending are expecting to hear more about marijuana and seizures, a cheaper MS drug, and whether sleep apnea leads to dementia. A team from MD Magazine will be at the conference with daily news reports and video interviews.
A Quix Test is an accurate way to find selective canal involvement in Benign Paroxysmal Positional Vertigo (BPPV) patients in many cases, according to Kevin Coughlin of Florida State University College of Medicine in Tallahassee, FL. The study will be presented in a poster session on Apr. 18 at the American Academy of Neurology meeting in Washington, DC.
Pathological vertebral artery (VA) abnormalities can be identified in acute vestibular syndrome (AVS) patients with the use of an axial T2 MRI scan, according to Jorge Kattah, MD, a neurologist at OSF Saint Francis Medical Center in Peoria, IL. This study will be presented in a poster session on Apr. 18 at the American Academy of Neurology meeting in Washington, DC.
The macular inner retinal layer thickness differs between individuals with neuromyelitis optica (NMO) and multiple sclerosis (MS), according to lead author Richard Loeb. The study will be presented in a poster session on Apr. 18 at the American Academy of Neurology meeting in Washington, DC. The finding should help physicians distinguish between the ailments.
Altering the Optics of Cardiovascular Disease: How the CANTOS Findings are Changing Physicians' Approach to CVD
Replication of 'Marshmallow Test' Reveals Delayed Gratification May Be Less Predictive of Later Outcomes